| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.22 | 8e-05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0004 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |